Gambir

DB14298Investigational

Gambir is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Mechanism: Pharmacologically active on Fatty acid synthase and Gag-Pol polyprotein
Curator reviewed
Also known as: Catechu · Gambir (Uncaria Gambir) · Gambir Leaf · Nauclea Gambir Leaf · Ourouparia Gambir Leaf

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

8Marketed productsAcross 2 countries and 6 labellers

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Gambir, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.